TABLE I.

Benefits of early patient-group input

Benefits for …
Sponsors	Patients
▪ Clearer, more focused understanding of unmet need and therapeutic burden ▪ Awareness of opportunities for expanding indications and more appropriate targets ▪ Improved clinical trial design, selection of optimum study participants, endpoints, and clinical sites ▪ Faster trial recruitment and greater patient compliance with the protocol ▪ Fewer costly and time-consuming adjustments during the clinical trial	▪ Less burdensome study protocols ▪ More meaningful and relevant study endpoints ▪ Increased likelihood of participation and retention in cancer clinical trials ▪ Increased chance of developing an important treatment for their disease